Amyloidosis
Conditions
Brief summary
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis. The main question it aims to answer is: Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients Participants will be asked to: * Download the MyFitnessPal application on their smartphone and view an online tutorial * After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone. * complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application
Interventions
OTHERTracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
Amyloidosis patients will use MyFitnessPal application to track dietary intake and use of herbal/alternative supplements in from week 2-9. Patient's usage of the application and questionnaires completed by the patient at the start, Week 2 and Week 10 will determine feasibility.
Sponsors
Barbara Ann Karmanos Cancer Institute
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years of age or older * Diagnosed with any type of amyloidosis * Speak, read and write in English * Willing to use the MyFitnessPal app on their own smartphone
Exclusion criteria
* a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment * cognitive or perceptual disturbances
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adherence Rate | 56 days | The adherence is defined by the status (yes vs. no) of data recording per day; The adherence rate will be calculated by the ratio of the number of days of adherence to the total number of days of trial (i.e., 56 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Subsequent adherence rate | 63 days (= 56 days + Week 10) | The subsequent adherence is the status of data recording per day during the third phase (Week 10) of trial participation (i.e., 7 days); The subsequent adherence rate will be calculated by the ratio of the number of days of adherence during the third phase (Week 10) of trial participation (i.e., 7 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey. |
Countries
United States
Contacts
CONTACTJeffrey Zonder, MD
PRINCIPAL_INVESTIGATORJeffrey Zonder, MD
Barbara Ann Karmanos Cancer Institute
Outcome results
None listed